Location: Home
  • search
  • go
  • Relate News
  • 8/7/2020Pfizer/Basilea's NDA for Antifungal Isavuconazole (Cresemba) Accepted ...
  • 8/7/2020ImmVira and Shanghai Pharma Enter Deal for Novel Intratumoral Oncolyti...
  • 8/7/2020WSJ: Drug Industry's China Habit Will Take Time to Kick
  • 8/6/2020U.S. Introduces A 'Buy American First' Pharma Executive Order
  • 8/6/2020CDE Issues the Filing Requirements and Procedures for Sub-packaging of...
  • 8/6/2020NMPA Publicizes the List of Reference Formulations for Generic Drug Eq...
  • 8/6/2020NMPA Solicits Comments on the Draft Interim Rules for Domestic Agents ...
  • 8/6/2020I-Mab Files IND for Eftansomatropin Pivotal Trial in Pediatric Patient...
  • 8/6/2020Bayer's China Business Undermined by VBP in Q2/2020
  • 8/5/2020Chi-Med Renews Plan for Hong Kong Listing in 2021
  • 8/5/2020Transgene Disposes A Minor Stake in Tasly BioPharma
  • 8/5/2020Review of Chinese Pharma Deals, R&D and Regulatory Developments in H1/...
  • 8/3/2020G1 Therapeutics and Simcere Enter License Deal for Trilaciclib in Grea...
  • 8/3/2020NHSA Solicits Feedbacks on the 2020 NRDL Revision Work Plan
  • 8/3/2020CDE Solicits Comments on the Guidance Principles on Real World Data Us...
  • 8/3/2020CDE Solicits Comments on the Technical Guidelines for Clinical Pharmac...
  • 8/3/2020CDE Solicits Comments on the Technical Guidelines for Model-led Drug R...
  • 8/3/2020CDE Solicits Comments on the Technical Guidelines for Population Pharm...
  • 8/3/2020CDE Solicits Comments on the Technical Guidelines on Bioequivalence St...
  • 8/3/2020CDE Solicits Comments on the Guidelines for Research and Validation of...
  • 8/3/2020NMPA Issues the Guidelines for Clinical Trials of Bevacizumab and Adal...
  • 8/3/2020AstraZeneca's Q2 Growth Dragged Down by China Decline
  • 8/1/2020Review of Chinese Drug Evaluation and Registration in 2019
  • 8/1/2020NHSA Issues the Interim Measures for Administration of Basic Medical I...
  • 7/31/2020Financial-related Company News in Brief
  • 7/31/2020CDE Solicits Comments on Four Draft Technical Guidelines
  • 7/31/2020Harbour BioMed Enters Strategic Partnership with Viva Biotech on Incub...
  • 7/31/2020Gan & Lee Pharmaceuticals Initiates First-in Human Phase 1 Clinica...
  • 7/31/2020NMPA Suspends Import of Sanyo Chemical's Methoxyphenamine
  • 7/30/2020NHC Issues Notice to Step Up Single Disease Group Quality Control and ...
  • Page:87/333 Total number of articles:9989: [First][<<] [85] [86] [87] [88] [89] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group